Join Genesis Therapeutics as an ML Research Engineer (New Grad)
Genesis Therapeutics is at the forefront of AI and biotechnology, creating a world-class machine learning (ML) team in an industry that has long underutilized computational methods. We are developing the premier molecular generation and property prediction platform globally, addressing a critical need in the drug discovery process. Your role will drive groundbreaking research that accelerates the discovery of treatments for a wider range of diseases, faster than ever before.
Genesis Therapeutics unifies AI and biotech to discover novel and breakthrough treatments for patients with severe and debilitating conditions. Founded on pioneering molecular ML research, we have established ourselves as the leader in AI for small molecule drug discovery. Our team of top biotech leaders and expert drug hunters collaborates with deep learning researchers and software engineers to push the boundaries of predictive and generative AI technologies for molecules.
Our state-of-the-art molecular AI platform, GEMS (Genesis Exploration of Molecular Space), accelerates and optimizes small molecule drug discovery, allowing us to identify first-in-class and best-in-class small molecule drugs for challenging and undruggable targets. Utilizing GEMS, we’ve built a robust internal pipeline and formed two significant AI platform collaborations with Eli Lilly and Genentech, encompassing various therapeutic areas.
With over $280M in funding, including a recent $200M series B in August 2023 from leading technology and biotech investors such as Andreessen Horowitz, Rock Springs Capital, and T. Rowe Price, Genesis Therapeutics stands on solid financial ground.
Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are committed to being an inclusive workplace and an Equal Opportunity Employer.
Finding the best talent is our top priority at Genesis Therapeutics. If you are interested in potential recruitment partnerships, please reach out to .